Despite concerns that an increasing number of insured individuals could mean longer wait times for doctors' appointments, a new study found that the availability for primary care physicians improved for individuals obtaining Medicaid improved in Michigan after the implementation of the Affordable Care Act.
Access to health insurance and doctor availability are connected, at least in the state of Michigan, according to a University of Michigan study.
The study found that the availability for primary care physicians improved for individuals obtaining Medicaid during the first few months the state implemented the Healthy Michigan Plan under the Affordable Care Act, a timeframe that showed more than 350,000 previously uninsured adults joining the plan.
Researchers with the University of Michigan Institute for Healthcare Policy and Innovation used the "secret shopper" survey method and called hundreds of clinics in the state of Michigan posing as prospective patients who needed routine health check ups.
During their investigation, researchers found that 49% of clinics offered an appointment before the expansion and 55% of clinics offered an appointment after the expansion. Before and after expansion, these clinics offered appointments within the same wait times, which was about 1 week.
The study also found that appointment offerings for patients with private insurers came at a higher rate than Medicaid-insured patients, about 88% before and 86% after the expansion and were offered within the same wait times as those with Medicaid coverage—1 week.
“Getting appointments as new patients is a challenging process” Matthew M. Davis, MD, MAPP, senior author of the study and professor of pediatrics, internal medicine, public policy and public health at U-M, said in a statement. "This study illustrates that although fewer practices accept Medicaid than accept private insurance, expanding access to coverage in Michigan has not made it more difficult to get an appointment as a new patient. That is good news for patients in Michigan."
While researchers encountered exceptions to their findings, they learned through this study the difficulty many clinical staff’s face when scheduling appointments for patients.
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Research Reveals the Role of Structural Racism in Lung Cancer Risk
December 7th 2023Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.
Read More
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More